Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.08 USD | -0.65% | -3.80% | -7.88% |
03-06 | Transcript : ESSA Pharma Inc. - Shareholder/Analyst Call | |
03-06 | Norway's wealth fund pushes for more women on emerging market company boards | RE |
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 368M 270M 21.52B |
---|---|---|---|---|---|
Net income 2024 * | -48M -35.15M -2.81B | Net income 2025 * | -78M -57.12M -4.56B | EV / Sales 2024 * | - |
Net cash position 2024 * | - 0 0 | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-7.66
x | P/E ratio 2025 * |
-5.45
x | Employees | 50 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 97.72% |
Latest transcript on ESSA Pharma Inc.
1 day | -0.65% | ||
1 week | -3.80% | ||
Current month | -28.39% | ||
1 month | -28.39% | ||
3 months | -21.95% | ||
6 months | +37.56% | ||
Current year | -7.88% |
Managers | Title | Age | Since |
---|---|---|---|
David Parkinson
CEO | Chief Executive Officer | 73 | 23/06/15 |
David Wood
DFI | Director of Finance/CFO | 66 | 30/09/13 |
Peter Virsik
COO | Chief Operating Officer | - | 31/07/16 |
Members of the board | Title | Age | Since |
---|---|---|---|
Franklin Berger
BRD | Director/Board Member | 74 | 04/03/15 |
Sanford Zweifach
BRD | Director/Board Member | 68 | 30/07/19 |
Richard Glickman
CHM | Chairman | 65 | 30/09/10 |
Date | Price | Change | Volume |
---|---|---|---|
26/04/24 | 6.08 | -0.65% | 178,467 |
25/04/24 | 6.12 | -2.08% | 64,770 |
24/04/24 | 6.25 | -2.34% | 41,308 |
23/04/24 | 6.4 | 0.00% | 130,486 |
22/04/24 | 6.4 | +1.27% | 122,377 |
Delayed Quote Nasdaq, April 26, 2024 at 09:00 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-7.88% | 269M | |
+1.51% | 42.75B | |
+49.11% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- EPIX Stock